Evaluation of Triple Antibiotic Paste Pulp Therapy Compared to Vitapex in Primary Molars. (NCT04547764) | Clinical Trial Compass
CompletedPhase 3
Evaluation of Triple Antibiotic Paste Pulp Therapy Compared to Vitapex in Primary Molars.
Saudi Arabia54 participantsStarted 2017-06-01
Plain-language summary
The aim of the study was to compare the clinical and radiographic success of triple antibiotic paste (TAP) which includes (metronidazole, ciprofloxacin, and minocycline) and Vitapex (calcium hydroxide/iodoform paste) for root canal treatment of pulpally involved teeth.
Who can participate
Age range5 Years – 8 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Primary molars with at least one of the following signs and symptoms were eligible and were included in the study:
* badly decayed with signs of irreversible pulpitis,
* necrosis and chronic infection such as: pain or tenderness to percussion and palpation, abscess, fistula-opening, gingival swelling, grade II and greater pathological tooth mobility, evidence of periapical/bifurcation radiolucency,
All the teeth included, had physiological root resorption of less than one third of the root.
Exclusion Criteria
* Teeth showing radiographic evidence of excessive internal or external root resorption,
* perforated pulpal floor,
* excessive bone loss in furcation area involving the underlying tooth germ,
* non- restorable teeth were excluded from the study.